Pain management · 2025
Effect of ethyl chloride spray on pain, patient & nurse satisfaction, and adverse effects during IV cannulation: randomized control trial.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jelly Prasuna, Sharma Rakesh, Kumar Pradeep, Sonia Sonia, Sharma Suresh K, Payal Yashwant Singh
Аннотация
AIM: To evaluate patients' pain perception and satisfaction, with ethyl chloride spray compared to placebo during intravenous cannulation.
METHODS: A randomized, double-blinded, placebo-controlled trial in emergency-observation ward of a tertiary-care-hospital was conducted from February 2023 to January 2024. A total of 417 patients were randomly assigned to experimental (n = 209) or control group (n = 208). Patients underwent intravenous cannulation in antecubital fossa (left/right). Pain perception and patient satisfaction following the use of ethyl-chloride-spray (ECS) compared to placebo, assessed using a 0-10 Verbal-Numeric-Rating-Scale and satisfaction questionnaire. Nurses' satisfaction with ECS and placebo, evaluated by Likert-scale, along with the observation of adverse effects. Final data analyzed using STATA, included 404 participants (202 in each group).
RESULTS: Demographic, clinical profile, and baseline pain perception scores between groups did not show any significant differences. Experimental group reported significantly less pain than control (p < 0.001). Nurses found cannulation easier in 43% of experimental cases versus 33% in controls (p < 0.001). In experimental group, 81% of patients were satisfied and recommended ECS for future use. In both groups, no adverse effects were reported.
CONCLUSION: Ethyl chloride spray significantly reduced pain perception during intravenous cannulation. High levels of patient satisfaction and nurse endorsement for pain management during IV cannulation.
CLINICAL TRIAL REGISTRATION: https://ctri.nic.in/Clinicaltrials/login.php, identifier is CTRI/2019/09/021285.
METHODS: A randomized, double-blinded, placebo-controlled trial in emergency-observation ward of a tertiary-care-hospital was conducted from February 2023 to January 2024. A total of 417 patients were randomly assigned to experimental (n = 209) or control group (n = 208). Patients underwent intravenous cannulation in antecubital fossa (left/right). Pain perception and patient satisfaction following the use of ethyl-chloride-spray (ECS) compared to placebo, assessed using a 0-10 Verbal-Numeric-Rating-Scale and satisfaction questionnaire. Nurses' satisfaction with ECS and placebo, evaluated by Likert-scale, along with the observation of adverse effects. Final data analyzed using STATA, included 404 participants (202 in each group).
RESULTS: Demographic, clinical profile, and baseline pain perception scores between groups did not show any significant differences. Experimental group reported significantly less pain than control (p < 0.001). Nurses found cannulation easier in 43% of experimental cases versus 33% in controls (p < 0.001). In experimental group, 81% of patients were satisfied and recommended ECS for future use. In both groups, no adverse effects were reported.
CONCLUSION: Ethyl chloride spray significantly reduced pain perception during intravenous cannulation. High levels of patient satisfaction and nurse endorsement for pain management during IV cannulation.
CLINICAL TRIAL REGISTRATION: https://ctri.nic.in/Clinicaltrials/login.php, identifier is CTRI/2019/09/021285.